Needle Biopsy Market Synopsis

Needle Biopsy Market Size Was Valued at USD 1.2 Billion in 2023, and is Projected to Reach USD 2.13 Billion by 2032, Growing at a CAGR of 6.60% From 2024-2032.

A needle biopsy is one type of biopsy that involves taking a sample of cells or tissue from a specific region of the body for examination. In the process a thin tube with a sharp end referred to as the needle is passed through the skin and through the tissues that are targeted normally under the guidance of the diagnostic imaging technique like ultrasonic, computer tomography, or magnetic resonance imaging. The sample collected undergoes staining and is viewed under microscopy where one may determine the presence of infections, inflamed or cancerous cells. Fine-needle aspirations are relatively nonsurgical, comparatively harmless, and occur most often on body’s organs including the breast, liver, lung, and bone. This procedure aids not only in preliminary diagnosis of many ailments but also do not necessitate the more complex surgical approaches.

• The need for needle biopsy is on the recovery partially due to the rise in the frequency of chronic diseases including cancer, new imaging techniques, and shift towards the improved diagnosis processes that are less invasive. With a new approach, the most popular techniques for performing needle biopsies include fine needle aspiration and core needle biopsy due to the higher accuracy, safety, and lower costs when compared to conventional surgical biopsy. Milestones in the field of technology are on the use of imaging and robotic assisted technologies that have aided in boosting the probability and accuracy of needle biopsies, making the procedure popular in both developed and evolving markets of the world’s healthcare industry. Furthermore, the increasing understanding of the indications of disease identification at an early stage and a gradually increasing aged population who are prone to contract chronic diseases are also driving the demand for needle biopsy procedures.
• By type, the market is classified into software and services; based on application, it can be categorized into hyperautomation, RPA for business and finance, and other uses; according to the end-users, it is divided into large enterprises and small & medium enterprises; and finally, by geographical regions, the market is divided for the Americas, APAC, Europe, and the rest of the world. Depending on the type it can be fine needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy among others. Present-day usage covers oncology, pulmonology, urology, and many more fields. It has major uses in the field of medical by becoming the centre for hospitals, diagnostic centres and research institutes. North America has the largest market share due to increased technical development in the medical field and better health facilities and there is a faster growth rate in the Asia Pacific region because they are improving their healthcare facilities and the healthcare expenditure has been increasing. Some of the key developments observed in the players in this market include new product launches, strategic partnerships, and acquisitions that help them to strengthen their market portfolios and geographical presence over the next few years, which will further drive the market competition and innovation.

Needle Biopsy Market Trend Analysis

Increasing adoption of liquid biopsy techniques as a complementary or alternative diagnostic tool

• The few trends identified in the needle biopsy market are as follows The one major trend present in the needle biopsy market is the. Liquid biopsies are basically portability tests or examinations done on a liquid sample other than a solid tissue, which are mainly conducted on blood to diagnose cancer and other diseases. Although this technique brings genetic and molecular data about the tumors, it is a less invasive procedure compared to the biopsies for diagnosing the diseases in early stages or tracking the disease progression and developing individualized therapeutic strategies. It can be inferred that liquid biopsies obtained less invasiveness and carry lower risks for the patient and are advantage to the healthcare provider. In the same way, the improvement in new generation sequencing or NGS and molecular diagnostics are improving the specificity and the ability of the liquid biopsy, making them more popular in clinical practice. It is believed that this particular trend will further possibly redefine the future of the needle biopsy market based on the advancements in the system that help in early diagnosis of diseases and their specific treatment.

Development and integration of artificial intelligence (AI) and machine learning (ML) technologies

• New growth area for needle biopsy market is the application of artificial intelligence and machine learning that can help to make the diagnosis more precise of improve its efficiency. The permutation of AI and ML has the ability to help in analyzing tissue biopsy, to increase the accuracy of imaging, and in the interpretation of large datasets. These technologies may assist in performing biopsy by way of automation and in cutting the number of errors due to human factor; they may also provide more precise results. Additionally, there is capacity to detect patterns and outliers which cannot be easily achieved by normal processes which aids in early detection of some illness like cancer among others.
• This opportunity is particularly pressing in those geographical areas where access to highly specialized medical professionals is limited because AI can enhance the skills and knowledge of those already present within the healthcare system. Manufacturers shouldfocusing on AI & ML in needle biopsy their products, as doing so can provide a competitive advantage, particularly as more people seek more specialized, specific diagnostics. Main ideas Tech collaborations between tech companies, healthcare organizations, and academic institutions can drive the development of AI-assisted needle biopsy surgery for the future, and thereby benefit patient outcomes.

Needle Biopsy Market Segment Analysis:

Needle Biopsy Market is segmented on the basis of needle type, application, and end-user.

By Needle Type, Trephine Biopsy Needles segment is expected to dominate the market during the forecast period

• The market within which Trephine Biopsy Needles is likely to have the leading market share is the Needle Biopsy Market during the upcoming years. Trephine biopsy needles are usually large enough to take more extensive core biopsy of the bone or soft tissue and therefore allows for enhanced histological evaluation. This makes them useful especially in cases where the disease is extensive for instance bone marrow ailments, cancers and other diseases that need large tissue samples for proper assessment. It has been noted that these diseases are on the rise and patients need accurate diagnostic tools, which are encouraging the use of trephine biopsy needles. In addition, the same for improved technology and materials utilized in needle manufacturing has increased their safety and effectiveness and therefore the comfort of the patient therefore propelling their use by health care practitioners. Consequently, the consumption and growth rate of the trephine biopsy needles segment has boosted the segment’s leading position in the global needle biopsy market consistently.

By Application, Tumour/Cancer segment expected to held the largest share

• The growing rate of cancer cases across the world and the importance of needle biopsy in diagnosing or treating this disease will continue to propel the tumor/cancer segment market share in the near future. Both Fine Needle Aspiration and Core Needle Biopsies are of paramount importance since it helps to ensure that tissue samples can be obtained from tumors for its histopathological examination that will allow for proper diagnosis and cancer staging. Moreover, the shifting focus towards the identification of the neoplastic diseases at an early stage and the growing relevance of targeted therapies also entails the need for more sensitive and minimally invasive diagnostic approaches.
• Furthermore, innovations have also made imaging techniques get improved and biopsy needles hence improving the yield and safety of needle biopsies thus making them oncologists favorite techniques. It has been driven because of the increased awareness towards the cancer screening programs and due to the escalation in the health care sector especially in the emerging areas, the tumor/cancer segment is dominating in the global market of needle biopsy.

Needle Biopsy Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast period

• The Asia Pacific needle biopsy market could attract highest growth percentages over the forecast timeframe, owing to variety of drivers. There has been a constant rise in the healthcare sector in the region which has in particular enhanced the spending on healthcare thus supporting the use of better diagnostic procedures. With rapidly increasing incidence of cancers and other chronic illnesses particularly in large populated regions like China and India there is increased need to embrace advanced and least invasive sampling techniques like needle biopsies.
• In addition, growing governments focusing on early diagnosis and treatment of diseases, along with increasing awareness among health care service providers and patients favoring the growth of the global Dental CAD/CAM market. Another factor is the increase in foreign investments and partnership with Medical device manufacturing companies abroad, which are also improving the development of higher quality products and the presence of advanced biopsy technologies in the market. Therefore, it can be predicted that the Asia Pacific needle biopsy market is also likely to progress at a faster growth rate and can outperform other regions in terms of market share during the forecast period.

Active Key Players in the Needle Biopsy Market

• AMECATH (Egypt)
• AprioMed AB (Sweden)
• Argon Medical Devices (U.S.)
• B. Braun SE (Germany)
• BD (U.S.)
• Boston Scientific Corporation (U.S.)
• Cardinal Health (U.S.)
• Cook Group (U.S.)
• HAKKO CO.,LTD. (Japan)
• Hologic, Inc. (U.S.)
• INRAD, Inc. (U.S.)
• Medax (Italy)
• Merit Medical Systems. (U.S.)
• MÖLLER Medical GmbH (Germany)
• PAJUNK (Germany)
• ST. STONE MEDICAL DEVICES PVT. LTD. (India)
• Swastik Enterprise (India)
• Tsunami Medical (Italy)
• weLLgo Medical Products GmbH (Germany)
• ZAMAR CARE. (Croatia), and Other key Players

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. NEEDLE BIOPSY MARKET BY NEEDLE TYPE (2017-2032)
   1. NEEDLE BIOPSY MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. TREPHINE BIOPSY NEEDLES
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. KLIMA STERNAL NEEDLE
   5. SALAH NEEDLE ASPIRATION NEEDLE
   6. JAMSHIDI NEEDLE
   7. OTHERS
7. NEEDLE BIOPSY MARKET BY APPLICATION (2017-2032)
   1. NEEDLE BIOPSY MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. TUMOUR/CANCER
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. BREAST
   5. LUNG
   6. PROSTATE
   7. COLON
   8. STOMACH
   9. LIVER
   10. CERVIX UTERI
   11. THYROID
   12. INFECTION
   13. INFLAMMATION
   14. OTHERS
8. NEEDLE BIOPSY MARKET BY END USER (2017-2032)
   1. NEEDLE BIOPSY MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. HOSPITALS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. DIAGNOSTIC CENTRES
   5. BIOPSY LABS
   6. AMBULATORY SURGICAL CENTRES
   7. ACADEMIC AND RESEARCH ORGANIZATIONS
   8. OTHERS
9. COMPANY PROFILES AND COMPETITIVE ANALYSIS
   1. COMPETITIVE LANDSCAPE
      1. Competitive Positioning
      2. NEEDLE BIOPSY Market Share By Manufacturer (2023)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
   2. AMECATH (EGYPT)
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
   3. APRIOMED AB (SWEDEN)
   4. ARGON MEDICAL DEVICES (U.S.)
   5. B. BRAUN SE (GERMANY)
   6. BD (U.S.)
   7. BOSTON SCIENTIFIC CORPORATION (U.S.)
   8. CARDINAL HEALTH (U.S.)
   9. COOK GROUP (U.S.)
   10. HAKKO CO.,LTD. (JAPAN)
   11. HOLOGIC, INC. (U.S.)
   12. INRAD, INC. (U.S.)
   13. MEDAX (ITALY)
   14. MERIT MEDICAL SYSTEMS. (U.S.)
   15. MÖLLER MEDICAL GMBH (GERMANY)
   16. PAJUNK (GERMANY)
   17. ST. STONE MEDICAL DEVICES PVT. LTD. (INDIA)
   18. SWASTIK ENTERPRISE (INDIA)
   19. TSUNAMI MEDICAL (ITALY)
   20. WELLGO MEDICAL PRODUCTS GMBH (GERMANY)
   21. ZAMAR CARE. (CROATIA)
10. GLOBAL NEEDLE BIOPSY MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Needle Type
       4. Historic And Forecasted Market Size By Application
       5. Historic And Forecasted Market Size By End User
       6. Historic And Forecasted Market Size By Country
          1. USA
          2. Canada
          3. Mexico
    3. EASTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Russia
          2. Bulgaria
          3. The Czech Republic
          4. Hungary
          5. Poland
          6. Romania
          7. Rest Of Eastern Europe
    4. WESTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Germany
          2. United Kingdom
          3. France
          4. The Netherlands
          5. Italy
          6. Spain
          7. Rest Of Western Europe
    5. ASIA PACIFIC
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. China
          2. India
          3. Japan
          4. South Korea
          5. Malaysia
          6. Thailand
          7. Vietnam
          8. The Philippines
          9. Australia
          10. New-Zealand
          11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Turkey
          2. Bahrain
          3. Kuwait
          4. Saudi Arabia
          5. Qatar
          6. UAE
          7. Israel
          8. South Africa
    7. SOUTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Brazil
          2. Argentina
          3. Rest of South America
11. INVESTMENT ANALYSIS
12. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies